First Oral Drug for Multiple Sclerosis Among Active Pharmaceutical Ingredients Added to Upgraded Pharmaceutical Substances

First Oral Drug for Multiple Sclerosis Among Active Pharmaceutical Ingredients Added to Upgraded Pharmaceutical Substances

Stuttgart, Germany – Thieme Publishing Group announces that “Pharmaceutical Substances Version 3.4” is now online. Compiled by Prof. A. Kleemann, Prof. J. Engel, Prof. B. Kutscher and Dr. D. Reichert, renowned leaders in the field, this comprehensive electronic reference to every significant pharmaceutical compound contains syntheses, patents and applications of all FDA approved active pharmaceutical ingredients (APIs) and is available through Thieme Chemistry (thieme-chemistry.com).

"With this release we have added 16 new API monographs, most of them have been approved recently," stated Prof. Dr. Axel Kleemann. "Among these are included Fingolimod, the first oral drug for Multiple Sclerosis, and the 3rd taxane anticancer drug Cabazitaxel. Along with these additions more than 40 entries have been updated."

Developed in association with InfoChem and FIZ Chemie, this digital version of the information resource is a web-based, easy-to-navigate portal that utilizes standard browser technology. This latest upgrade, brings the total number of APIs to 2,511 and includes 47 updated syntheses.

Endusers appreciate the system's easy-to-use interface, which facilitates locating data rapidly and allows them to graphically search structures using ISIS Draw, ChemDraw or a built-in Java Applet. “Pharmaceutical Substances 3.4” supports both ChemDraw 9.0.1 and 10.0 and is compatible with Internet Explorer and Mozilla Firefox browsers on PC's and Safari 2.0 on MAC's running OS X.

About InfoChem

InfoChem GmbH (infochem.de), based in Munich, Germany, is a market leader in structure and reaction handling and retrieval. Founded in 1989, InfoChem focuses on the production and marketing of new chemical information products, including structural and reaction databases, and the development of software tools required for these applications. The main software tools provided are the InfoChem Fast Search Engine (ICFSE), the InfoChem Chemistry Cartridge for Oracle (ICCARTRIDGE), and the widely used InfoChem reaction classification algorithm, CLASSIFY. Springer (Heidelberg) has held a majority interest in InfoChem since 1991.

About Thieme

Thieme Publishing Group is a privately held STM publishing house employing more than 950 people and maintains offices in New York, Delhi, Stuttgart and three other locations in Germany. Founded in 1886, the Thieme name has become synonymous with high quality and excellence in medical and scientific publishing. Today, Thieme is the market leading publisher of neurosurgical content and holds strong market positions in orthopedics, radiology, anatomy and chemistry, among other specialties. Thieme publishes 137 peer-reviewed journals and over 500 new books annually. The company also has a rapidly growing array of web-based products in medicine and science. Popular online products include Thieme eJournals and the Thieme E-Book Library, which are accessible via thieme-connect.com, Thieme's platform for electronic products.

Contact Thieme

Clifton Johnson
Marketing Associate, Institutional Marketing
Thieme Publishing Group
Ruedigerstrasse 14
70469 Stuttgart
Germany
Tel: +49-711-8931-926
Fax: +49-711-8931-777
clifton.johnson (at) thieme.de

This release was published on openPR.